Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 83Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Ranexa

PharmaCompass

01

Brand Name : Ranexa

Ranolazine

arrow
CPhI India 2024
Not Confirmed

Brand Name : Ranexa

arrow
CPhI India 2024
Not Confirmed

Ranolazine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 9

2019 Revenue in Millions : 216

Growth (%) : -96

blank

02

Brand Name : Ranexa

Ranolazine

arrow
CPhI India 2024
Not Confirmed

Brand Name : Ranexa

arrow
CPhI India 2024
Not Confirmed

Ranolazine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 10

2020 Revenue in Millions : 9

Growth (%) : 11

blank

03

Brand Name : Ranexa

Ranolazine

arrow
CPhI India 2024
Not Confirmed

Brand Name : Ranexa

arrow
CPhI India 2024
Not Confirmed

Ranolazine

Main Therapeutic Indication : Cardiovascular

Currency : USD

2015 Revenue in Millions : 510

2014 Revenue in Millions : 588

Growth (%) : 15%

blank

04

Brand Name : Ranexa

Ranolazine

arrow
CPhI India 2024
Not Confirmed

Brand Name : Ranexa

arrow
CPhI India 2024
Not Confirmed

Ranolazine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2016 Revenue in Millions : 677

2015 Revenue in Millions : 588

Growth (%) : 15

blank

05

Brand Name : Ranexa

Ranolazine

arrow
CPhI India 2024
Not Confirmed

Brand Name : Ranexa

arrow
CPhI India 2024
Not Confirmed

Ranolazine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2017 Revenue in Millions : 717

2016 Revenue in Millions : 677

Growth (%) : 6

blank

06

Brand Name : Ranexa

Ranolazine

arrow
CPhI India 2024
Not Confirmed

Brand Name : Ranexa

arrow
CPhI India 2024
Not Confirmed

Ranolazine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2018 Revenue in Millions : 758

2017 Revenue in Millions : 717

Growth (%) : 6%

blank

07

Brand Name : Ranexa

Ranolazine

arrow
CPhI India 2024
Not Confirmed

Brand Name : Ranexa

arrow
CPhI India 2024
Not Confirmed

Ranolazine

Main Therapeutic Indication : Cardiovascular

Currency : USD

2014 Revenue in Millions : 13.60%

2013 Revenue in Millions :

Growth (%) :

blank

08

Brand Name : Ranexa

Ranolazine

arrow
CPhI India 2024
Not Confirmed

Brand Name : Ranexa

arrow
CPhI India 2024
Not Confirmed

Ranolazine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2019 Revenue in Millions : 216

2018 Revenue in Millions : 758

Growth (%) : -72

blank